Eli Lilly Makes $2.75 Billion Bet on AI-Powered Drug Discovery (opens in new tab)
Pharmaceutical titan Eli Lilly wants to bring medications developed with AI to market. To that end, the company has struck a $2.75 billion deal, announced
Read the original article